Camp4 Therapeutics Corporation
CAMP
$4.42
$0.020.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -107.10% | -66.69% | -55.25% | -3.68% | -4.16% |
| Total Depreciation and Amortization | 8.06% | 3.39% | -3.36% | -1.63% | -2.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 938.37% | 604.58% | 517.38% | 40.06% | 30.33% |
| Change in Net Operating Assets | 856.80% | 441.97% | 1,077.31% | -73.45% | -602.99% |
| Cash from Operations | 37.31% | 46.11% | 35.14% | -2.34% | -6.27% |
| Capital Expenditure | 76.20% | 100.00% | 36.73% | -28.74% | 13.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 82.84% | 105.11% | 44.90% | -20.19% | 13.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 73.94% | 92.61% | 74.76% | 52.77% | 41.63% |
| Issuance of Common Stock | -24.63% | -24.64% | -24.72% | 52,811.65% | 43,345.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 649.56% | 565.60% | 565.60% | 1,535.37% | -454.61% |
| Cash from Financing | 4.73% | 6.11% | 5.90% | 8,327.41% | 5,771.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.04% | 123.67% | 79.64% | 251.70% | 158.99% |